Introduction

K-Bio fever continues to be strong this year. From early this year, domestic pharmaceutical 

and biopharma companies have successfully developed new drugs and exported related 

technologies. They develop new drugs through open-innovation and export not only novel 

medicines and but also the platform technologies, raising the status of Korean bioproducts 

in the world.

Against this backdrop, pharmaceutical and biopharma companies will mobilize 10 trillion won 

by 2023 to promote bio and health sectors, which are considered the next-generation 

core industries. The government, by expanding the bio-and-health-related R&D budget 

by 30%, actively supporting the boom in the bio industry.

One area that is garnering attention in the pharmaceutical industry is the platform technologies, 

which have the potential to be the foundation of new drug development. The next-generation drug development platforms not only raise the possibility of successful identification of drug candidates 

but are becoming the original technology that increases the diversity and efficiency 

in developing new molecules.

Thus, the R&D investment on new drug development is escalating across the globe, 

and platform technologies are rising as a new growth engine for pharma 

and biopharma companies. It was also applied in developing the COVID-19 vaccine recently.

Utilizing technologies like artificial intelligence, big data, organoid and 3D-printing, 

the platform technology is the core driver in improving efficiency in drug development process.

 Thus, the application of this technology 

can reduce time and cost in novel drug research and development, 

and it can enable the development of other new drugs from one molecule 

and open the opportunity for pharmaceutical firms to out-license drugs.

As such, the Financial News is hosting the 13th Seoul International New Pharmaceuticals Forum 

as a venue to discuss new opportunities platform technologies provide in drug development 

with the experts and representatives from related organizations. 

Overview

Title : ​The 13th Seoul International New Pharmaceuticals Forum

Theme : Transition in the New Drug Development Platforms

Date : ​June 17th, 2021(Thu) 09:00~12:00

Venue : ​Orchid, The Westin Josun Seoul Hotel

Hosts : ​The Financial News,

             Korea Research Institute of Chemical Technology

Sponsors : Ministry of Health and Welfare, Ministry of Science and ICT, 

        Ministry of Trade, Industry and Energy,

        Ministry of Food and Drug Safety, 

        Korea Pharmaceutical and Bio-Pharma Manufacturers Association, 

        Korea Biotechnology Industry Organization,

        Korea Research-based Pharma Industry Association

Contact : Seoul International New Pharmaceuticals Forum Bureau

     Tel. 02-6965-0026  

     Mail. cayley@fnmice.com